BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9414177)

  • 21. C/EBPβ LIP and c-Jun synergize to regulate expression of the murine progesterone receptor.
    Wang W; Do HN; Aupperlee MD; Durairaj S; Flynn EE; Miksicek RJ; Haslam SZ; Schwartz RC
    Mol Cell Endocrinol; 2018 Dec; 477():57-69. PubMed ID: 29870755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
    Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
    Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development.
    Seagroves TN; Lydon JP; Hovey RC; Vonderhaar BK; Rosen JM
    Mol Endocrinol; 2000 Mar; 14(3):359-68. PubMed ID: 10707954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCAAT/enhancer binding protein β negatively regulates progesterone receptor expression in human glioblastoma cells.
    Hansberg-Pastor V; González-Arenas A; Camacho-Arroyo I
    Mol Cell Endocrinol; 2017 Jan; 439():317-327. PubMed ID: 27663075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
    Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials.
    Ossipow V; Descombes P; Schibler U
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8219-23. PubMed ID: 8367486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regenerative changes in C/EBP alpha and C/EBP beta expression modulate binding to the C/EBP site in the c-fos promoter.
    Diehl AM; Yang SQ
    Hepatology; 1994 Feb; 19(2):447-56. PubMed ID: 8294101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
    Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
    J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deprivation of protein or amino acid induces C/EBPbeta synthesis and binding to amino acid response elements, but its action is not an absolute requirement for enhanced transcription.
    Thiaville MM; Dudenhausen EE; Zhong C; Pan YX; Kilberg MS
    Biochem J; 2008 Mar; 410(3):473-84. PubMed ID: 18052938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of C/EBPβ-LAP and C/EBPβ-LIP in early adipogenic differentiation of human white adipose-derived progenitors and at later stages in immature adipocytes.
    Lechner S; Mitterberger MC; Mattesich M; Zwerschke W
    Differentiation; 2013 Jan; 85(1-2):20-31. PubMed ID: 23314288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and significance of Bmi-1 in breast cancer].
    Feng Y; Song LB; Guo BH; Liao WT; Li MZ; Liu WL; Zeng MS; Zhang L
    Ai Zheng; 2007 Feb; 26(2):154-7. PubMed ID: 17298744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer.
    Pandya AY; Talley LI; Frost AR; Fitzgerald TJ; Trivedi V; Chakravarthy M; Chhieng DC; Grizzle WE; Engler JA; Krontiras H; Bland KI; LoBuglio AF; Lobo-Ruppert SM; Ruppert JM
    Clin Cancer Res; 2004 Apr; 10(8):2709-19. PubMed ID: 15102675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
    Recăreanu F; Simionescu C; Georgescu CV; Pirici E
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1059-64. PubMed ID: 22119825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
    Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
    Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
    Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.